DS
ONC

David Shaw’s BeOne Medicines Ltd ONC Stock Holding History

David Shaw’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-158,200
Closed -$48M – 5006
2025
Q2 		$38.3M Buy
158,200
+17,626
+13% +$4.32M 0.03% 691
2025
Q1 		$38.3M Buy
+140,574
New +$32.9M 0.03% 593
2024
Q1 		– Sell
-2,727
Closed -$492K – 4819
2023
Q4 		$492K Buy
+2,727
New +$493K ﹤0.01% 3519
2021
Q1 		– Sell
-51,120
Closed -$13.2M – 4554
2020
Q4 		$13.2M Buy
+51,120
New +$14.1M 0.01% 1206
2019
Q1 		– Sell
-5,256
Closed -$737K – 3988
2018
Q4 		$737K Buy
5,256
+4,032
+329% +$535K ﹤0.01% 2863
2018
Q3 		$211K Sell
1,224
-2,094
-63% -$352K ﹤0.01% 3522
2018
Q2 		$510K Buy
+3,318
New +$592K ﹤0.01% 3107
2018
Q1 		– Sell
-6,866
Closed -$930K – 3826
2017
Q4 		$671K Sell
6,866
-13,173
-66% -$1.21M ﹤0.01% 2808
2017
Q3 		$2.07M Buy
+20,039
New +$1.49M ﹤0.01% 1996
2017
Q2 		– Sell
-29,273
Closed -$1.07M – 3574
2017
Q1 		$1.07M Buy
+29,273
New +$1.07M ﹤0.01% 2260

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

David Shaw's ONC Position: Q3 2025 in Review

David Shaw sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 158,200 shares — an estimated $48M sold.

David Shaw first reported a position in ONC in Q1 2017 and held it in 10 quarters. The position peaked at $38.3M in Q2 2025. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • David Shaw reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • David Shaw sold 158,200 BeOne Medicines Ltd shares in Q3 2025, an estimated $48M.
  • David Shaw first reported a position in BeOne Medicines Ltd in Q1 2017 and held it in 10 quarters.
  • David Shaw's BeOne Medicines Ltd position peaked at $38.3M in Q2 2025.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.